CML is characterized by the excessive production of neutrophils and their precursors, while BCR::ABL1-negative MPNs are primarily driven by mutations in JAK2, CALR, or MPL. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.